Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG known ✓ | P37231 | 5/20 | 0.45 |
| ▸ | HDAC11 known ✓ | Q96DB2 | 4/20 | 0.45 |
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.45 |
| ▸ | PDE4A known ✓ | P27815 | 1/20 | 0.45 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 8/20 | 0.53 |
| ▸ | CES1 | P23141 | 8/20 | 0.53 |
| ▸ | CES2 | O00748 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 5/20 | 0.45 |
| ▸ | PPARA | Q07869 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28875 | 1.00 | FAAH (0.53) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL5533296 | 0.98 | FAAH (0.55) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL540827 | 0.98 | FAAH (0.55) | FAAHCES1CES2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6565479 | 0.90 | FAAH (0.61) | FAAHCES1MEN1KMT2AHSD17B10 | |
| Hydrochloric Acid SCHEMBL6565477 | 0.90 | FAAH (0.61) | FAAHCES1MEN1KMT2AHSD17B10 | |
| SCHEMBL28766942 | 0.89 | FAAH (0.50) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL532715 | 0.88 | FAAH (0.63) | FAAHCES1MEN1KMT2AHSD17B10 | |
| SCHEMBL532713 | 0.88 | FAAH (0.63) | FAAHCES1MEN1KMT2AHSD17B10 | |
| SCHEMBL27899377 | 0.87 | FAAH (0.48) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL28532297 | 0.85 | FAAH (0.43) | FAAHCES1CES2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114599334-A | Stable low pH personal care compositions and methods therefor | 高露洁-棕榄公司 | 2022-06-07 | — | — | CN | claimed |
| EP-2413879-B1 | CAPILLARY COMPOSITION FOR TREATING HAIR | L'ORÉAL (FR) | 2017-08-16 | — | — | EP | claimed |
| US-20120103358-A1 | CAPILLARY COMPOSITION FOR TREATING HAIR | L'OREAL (FR) | 2012-05-03 | — | — | US | claimed |
| US-20020012650-A1 | Hair cures and hair rinses, comprising quaternary ammonium compounds and having pearly luster effect | CLARIANT GMBH | 2002-01-31 | — | — | US | claimed |
| CN-115697290-A | Cosmetic compositions with enhanced color stability against retinoic acid precursors | 联合利华知识产权控股有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-114599334-A | Stable low pH personal care compositions and methods therefor | 高露洁-棕榄公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-113677321-A | Composition comprising a specific hyperbranched copolymer and 1, 3-propanediol and/or N-hydroxyoctanoylamide | 帝斯曼知识产权资产管理有限公司 | 2021-11-19 | — | — | CN | disclosed |
| CN-113164345-A | Cosmetic composition comprising a specific hyperbranched copolymer and an oil | 帝斯曼知识产权资产管理有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-113164795-A | Cosmetic composition comprising a dispersion of a specific hyperbranched copolymer and an acrylic polymer | 帝斯曼知识产权资产管理有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-113164373-A | Cosmetic composition comprising a specific hyperbranched copolymer and an organic UV filter | 帝斯曼知识产权资产管理有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-113164796-A | Cosmetic composition comprising a specific hyperbranched copolymer and an anionic emulsifier | 帝斯曼知识产权资产管理有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-113164359-A | Cosmetic composition comprising a specific hyperbranched copolymer and a nonionic emulsifier which is an ether or ester of a (poly) ethylene oxide | 帝斯曼知识产权资产管理有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-106309149-B | Emulsions comprising cationic emulsifiers based on methyldiisopropanolamine Quaternary ammonium Compounds | 赢创运营有限公司 | 2021-06-15 | — | — | CN | disclosed |
| CN-105434183-B | Formulations comprising esterquat compounds based on isopropanolamine and tetrahydroxypropylethylenediamine | 赢创运营有限公司 | 2021-01-01 | — | — | CN | disclosed |
| WO-2012139937-A2 | CATIONIC COSMETIC COMPOSITION | UNILEVER PLC (GB) | 2012-10-18 | — | — | WO | disclosed |
| US-20120259011-A1 | PERSONAL CARE COMPOSITIONS WITH CATIONIC DIESTERS AND DIHYDROXYPROPYL QUATERNARY AMMONIUM SALTS | CONOPCO, INC., D/B/A UNILEVER (US) | 2012-10-11 | — | — | US | disclosed |
| US-20120259010-A1 | CATIONIC COSMETIC COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2012-10-11 | — | — | US | disclosed |
| WO-2011128309-A1 | COMPOSITION AND TREATMENT PROCESS USING PUMICE PARTICLES | L'OREAL (FR) | 2011-10-20 | — | — | WO | disclosed |
| US-20080305056-A1 | STABLE, LOW VISCOSITY COSMETIC COMPOSITIONS | EVONIK GOLDSCHMIDT GMBH (DE) | 2008-12-11 | — | — | US | disclosed |
| US-20020012650-A1 | Hair cures and hair rinses, comprising quaternary ammonium compounds and having pearly luster effect | CLARIANT GMBH | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120259010-A1 | CATIONIC COSMETIC COMPOSITION | KCNN3, KCNN1, KCNN2 | PPARG 1537/4885HDAC11 736/4885ESR1 3824/4885 |
| US-20080305056-A1 | STABLE, LOW VISCOSITY COSMETIC COMPOSITIONS | QARS1, QPCTL, CUTA | PPARG 877/4885HDAC11 1735/4885ESR1 4002/4885 |
| US-20120259011-A1 | PERSONAL CARE COMPOSITIONS WITH CATIONIC DIESTERS AND DIHYDROXYPROPYL QUATERNARY AMMONIUM SALTS | IL33, DLAT, CUTA | PPARG 2306/4885HDAC11 1267/4885ESR1 2161/4885 |
| US-20120103358-A1 | CAPILLARY COMPOSITION FOR TREATING HAIR | POLE3, POLR1C, PUM1 | PPARG 3241/4885HDAC11 837/4885ESR1 3406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.